An Efficient Method for Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-like Cells Retaining Drug Metabolizing Activity-Reference-Cited by-同舟云学术

An Efficient Method for Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-like Cells Retaining Drug Metabolizing Activity

Published:2014 Issue:3 Volume:29 Page:237-243
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Kondo Yuki,Iwao Takahiro,Nakamura Katsunori,Sasaki Takamitsu,Takahashi Shogo,Kamada Noboru,Matsubara Tsutomu,Gonzalez Frank J.,Akutsu Hidenori,Miyagawa Yoshitaka,Okita Hajime,Kiyokawa Nobutaka,Toyoda Masashi,Umezawa Akihiro,Nagata Kiyoshi,Matsunaga Tamihide,Ohmori Shigeru

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference46 articles.

1. Reprogramming of human somatic cells to pluripotency with defined factors;Park;Nature,2008

2. Generation of human induced pluripotent stem cells from dermal fibroblasts;Lowry;Proc. Natl. Acad. Sci. USA,2008

3. Induction of pluripotent stem cells from adult human fibroblasts by defined factors;Takahashi;Cell,2007

4. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors;Takahashi;Cell,2006

5. Commitment of stem cells into functional hepatocytes;Ochiya;Differentiation,2010

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication;Journal of Biological Chemistry;2024-03

2. A highly efficient cell culture method using oxygen‐permeable PDMS‐based honeycomb microwells produces functional liver organoids from human induced pluripotent stem cell‐derived carboxypeptidase M liver progenitor cells;Biotechnology and Bioengineering;2024-01-07

3. Cell therapy in end-stage liver disease: replace and remodel;Stem Cell Research & Therapy;2023-05-25

4. Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver Characteristics;Pharmaceutics;2022-12-24

5. Developing tissue engineering strategies for liver regeneration;Engineered Regeneration;2022-03